Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Herbal remedies can cause adverse effects and need more safety research.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Taking the same medication under different brand names caused harmful side effects.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Finasteride can help with hair loss and prostate issues but may negatively affect mood and the nervous system.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Certain genetic variations are linked to hair loss in Mexican men.

Upadacitinib may effectively treat resistant lichen planopilaris.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride's potential harms are hard to accurately measure.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Patients should discuss risks with doctors before using finasteride for hair loss.

Finasteride can cause melasma, especially in people with darker skin.

Topical adenosine may effectively and safely treat hair loss.